Essex Investment Management’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
Essex Investment Management's FLGT Position: Q4 2022 in Review
Essex Investment Management sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 24,946 shares — an estimated $951K sold.
Essex Investment Management first reported a position in FLGT in Q4 2018 and held it in 16 quarters. The position peaked at $3.52M in Q3 2020. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.
- Essex Investment Management reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
- Essex Investment Management sold 24,946 Fulgent Genetics shares in Q4 2022, an estimated $951K.
- Essex Investment Management first reported a position in Fulgent Genetics in Q4 2018 and held it in 16 quarters.
- Essex Investment Management's Fulgent Genetics position peaked at $3.52M in Q3 2020.
- 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.
Based on Essex Investment Management's 13F filing for Q4 2022, filed 3 Feb 2023.